These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29076925)

  • 1. Circulating epithelial tumor cells as a prognostic tool for malignant melanoma.
    Pachmann K; Willecke-Hochmuth R; Schneider K; Kaatz M
    Melanoma Res; 2018 Feb; 28(1):37-43. PubMed ID: 29076925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.
    Koyanagi K; O'Day SJ; Gonzalez R; Lewis K; Robinson WA; Amatruda TT; Wang HJ; Elashoff RM; Takeuchi H; Umetani N; Hoon DS
    J Clin Oncol; 2005 Nov; 23(31):8057-64. PubMed ID: 16258104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.
    Pachmann K; Camara O; Kavallaris A; Krauspe S; Malarski N; Gajda M; Kroll T; Jörke C; Hammer U; Altendorf-Hofmann A; Rabenstein C; Pachmann U; Runnebaum I; Höffken K
    J Clin Oncol; 2008 Mar; 26(8):1208-15. PubMed ID: 18323545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer.
    Pachmann K; Dengler R; Lobodasch K; Fröhlich F; Kroll T; Rengsberger M; Schubert R; Pachmann U
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):59-65. PubMed ID: 17611779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma.
    Mocellin S; Del Fiore P; Guarnieri L; Scalerta R; Foletto M; Chiarion V; Pilati P; Nitti D; Lise M; Rossi CR
    Int J Cancer; 2004 Sep; 111(5):741-5. PubMed ID: 15252844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.
    Koyanagi K; O'Day SJ; Boasberg P; Atkins MB; Wang HJ; Gonzalez R; Lewis K; Thompson JA; Anderson CM; Lutzky J; Amatruda TT; Hersh E; Richards J; Weber JS; Hoon DS
    Clin Cancer Res; 2010 Apr; 16(8):2402-8. PubMed ID: 20371696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients.
    Pizon M; Schott DS; Pachmann U; Pachmann K
    Int J Oncol; 2018 Nov; 53(5):2289-2299. PubMed ID: 30226585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.
    Lucci A; Hall CS; Patel SP; Narendran B; Bauldry JB; Royal RE; Karhade M; Upshaw JR; Wargo JA; Glitza IC; Wong MKK; Amaria RN; Tawbi HA; Diab A; Davies MA; Gershenwald JE; Lee JE; Hwu P; Ross MI
    Clin Cancer Res; 2020 Apr; 26(8):1886-1895. PubMed ID: 32015020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases.
    Curry BJ; Myers K; Hersey P
    J Clin Oncol; 1999 Aug; 17(8):2562-71. PubMed ID: 10561323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.
    Palmieri G; Ascierto PA; Perrone F; Satriano SM; Ottaiano A; Daponte A; Napolitano M; Caracò C; Mozzillo N; Melucci MT; Cossu A; Tanda F; Gallo C; Satriano RA; Castello G
    J Clin Oncol; 2003 Mar; 21(5):767-73. PubMed ID: 12610172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study.
    Roland CL; Ross MI; Hall CS; Laubacher B; Upshaw J; Anderson AE; Lucci A
    Melanoma Res; 2015 Aug; 25(4):335-41. PubMed ID: 26011119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Epithelial Cell Characterization and Correlation with Remission and Survival in Patients with Thyroid Cancer.
    Lin JD; Liou MJ; Hsu HL; Leong KK; Chen YT; Wang YR; Hung WS; Lee HY; Tsai HJ; Tseng CP
    Thyroid; 2018 Nov; 28(11):1479-1489. PubMed ID: 30221579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study).
    Fusi A; Collette S; Busse A; Suciu S; Rietz A; Santinami M; Kruit WH; Testori A; Punt CJ; Dalgleish AG; Spatz A; Eggermont AM; Keilholz U
    Eur J Cancer; 2009 Dec; 45(18):3189-97. PubMed ID: 19793643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma.
    Joshi P; Jacobs B; Derakhshan A; Moore LR; Elson P; Triozzi PL; Borden E; Zborowski M
    Oncotarget; 2014 May; 5(9):2450-61. PubMed ID: 24811334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma.
    Klinac D; Gray ES; Freeman JB; Reid A; Bowyer S; Millward M; Ziman M
    BMC Cancer; 2014 Jun; 14():423. PubMed ID: 24915896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?
    Indini A; Roila F; Grossi F; Massi D; Mandalà M
    Am J Clin Dermatol; 2021 Jul; 22(4):511-522. PubMed ID: 34036489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse.
    Egberts F; Hitschler WN; Weichenthal M; Hauschild A
    Melanoma Res; 2009 Feb; 19(1):31-5. PubMed ID: 19104452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of prognostic factors in patients with nodular melanoma.
    Susok L; Stücker M; Bechara FG; Stockfleth E; Gambichler T
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2759-2764. PubMed ID: 33630139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma.
    Curry BJ; Myers K; Hersey P
    J Clin Oncol; 1998 May; 16(5):1760-9. PubMed ID: 9586889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients.
    Kiyohara E; Hata K; Lam S; Hoon DS
    Methods Mol Biol; 2014; 1102():513-22. PubMed ID: 24258996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.